Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Trading Statement

28 Jan 2005 09:00

Flying Brands Limited28 January 2005 Flying Brands Limited Trading Statement 28 January 2005, Jersey, Flying Brands is today providing an update on tradingfor the year ended 31 December 2004. Overview The Company has enjoyed a good performance overall for the year and hasbenefited from the actions that the management has taken to improve theefficiency of the business and revitalise its brands. Christmas trading has beendifficult for the Flying Flowers brand, but the Board anticipates that theCompany will still report double-digit earnings growth for 2004 and that it willmeet market expectations, albeit at the lower end of the range. Cash generationcontinues to be very good, as does online sales growth. Business by business highlights (annual basis) Gardening Direct: Sales overall were up on the year as a result of a number ofnew initiatives, including new product lines, price reductions, an improvedcatalogue format and successful reactivation of lapsed customers, all of whichshould help drive the brand forward in 2005. Flying Flowers: The strategy in 2004 focused on re-positioning the brand as amajor player in the low cost gift arena. After a strong H1, Flying Flowers, incommon with much of the retail sector, saw more difficult trading conditions inthe run up to Christmas, despite a late sales rally. The new gift categories,however, such as pot plants and teddy bears, tested well and will be rolled outin 2005. Listen2Books: The focus in H1 was to develop the product range and improvecustomer spend. Trading was consistently buoyant through H2, culminating in astrong Christmas performance, with sales driven by a steady stream of newproduct introductions, offering CDs as an alternative format to cassettes (whereavailable), and a promising trial of video and DVD titles tailored to the tastesof our database. These will be rolled out in 2005. Benham: Although remaining highly cash generative, Benham was unable to matchthe success of 2003, despite a full H2 programme. We are developing a newproduct strategy for this brand, which, together with a successfully implementednew operating system, should propel the brand back to growth in 2005. Flying Brands intends to announce its preliminary results for the year to 31December 2004 on 11 March 2005. For further information please contact: Flying Brands Limited 01376 575 010Mark Dugdale, Chief Executive Smithfield 020 7360 4900Nick BastinGeorge Hudson Notes to editors Jersey based Flying Brands Limited (LSE: FBDU) is a leading Home Shoppingcompany. Founded in 1965, it was admitted to the Official List of the LondonStock Exchange in 1993. The Group has the following brands: • Flying Flowers, the UK's largest flowers by post brand, despatching nearly one million bouquets a year• Gardening Direct, one of the UK's largest mail order bedding plants and gardening products operations• Listen2Books, the leading mail order audio books distributor• Benham, the first day cover stamps and coins collectables specialist More information can be found at: www.flyingbrands.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn
31st May 202211:00 amRNSPrice Monitoring Extension
31st May 20228:00 amRNSSubmission of FDA 510(k) Application for IB Zero G
30th May 202210:47 amRNSResult of AGM
5th May 20223:00 pmRNSNotice of AGM
3rd May 20222:21 pmRNSIB Broadens Quantitative Mapping
28th Apr 20225:52 pmRNSFinal Results
9th Mar 20223:08 pmRNSIQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 202211:12 amRNSTotal Voting Rights
8th Feb 20227:00 amRNSIssue of shares to Mayo Clinic
27th Jan 20227:00 amRNSImaging Biometrics LLC - Letter to Shareholders
4th Jan 20229:27 amRNSDirector/PDMR Shareholding
17th Dec 20217:37 amRNSIQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 202110:32 amRNSDirector's Interest
11th Nov 20218:52 amRNSAgreement with St. Jude Children’s Hospital
2nd Nov 20218:19 amRNSMD ANDERSON ADOPTS IB CLINIC
28th Oct 20214:00 pmRNSLetter to Shareholders
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20212:05 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202112:00 pmRNSPlacing
1st Oct 20218:17 amRNSCase Report on Clinical Value of IB Software
22nd Sep 20217:00 amRNSEU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 20217:00 amRNSIB Software Chosen for Accuracy and Automation
10th Sep 20217:00 amRNSUpdate on Phase I Clinical Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.